Malin Corporation | MLC - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
ALKERMES USD 662.09M 62.59M 2026-06
Avita Medical AUD 62.68M 77K 2025-12
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Eurofins Scientific SE EUR 2.49B 57M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Lonza CHF 3.57B 421M 2025-12
Malin Corporation EUR 1000K 500K 2024-12
Moderna USD 2.53B 139M 2026-06
Organon & Co USD 2.62B 116M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Revvity USD 1.28B 37.71M 2026-06
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Viatris USD 6.35B 464.5M 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06